Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.59 EUR | -1.67% | -9.92% | -34.00% |
2023 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | IntegraGen SA Announces Revenue Results for the First Half of 2023 | CI |
Business Summary
- supply of genomic research services: high-speed genotyping services, medium-speed genotyping services, and ultra-high-speed sequencing services for academic research institutions and pharmaceutical groups;
- sales of diagnostic solutions.
France accounts for 88% of net sales.
Number of employees: 57
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Genetic Biomakers
100.0
%
| 11 | 100.0 % | 13 | 100.0 % | +16.27% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 11 | 100.0 % | 13 | 100.0 % | +16.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bernard Courtieu
CEO | Chief Executive Officer | 60 | 07-09-05 |
Pierre Flamant
DFI | Director of Finance/CFO | - | - |
Francois Degrave
CTO | Chief Tech/Sci/R&D Officer | - | - |
Emmanuel Martin
COO | Chief Operating Officer | - | 06-06-30 |
Jean-Pol Detiffe
BRD | Director/Board Member | 51 | - |
Human Resources Officer | - | - | |
Berengere Genin
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | - | |
Jean-Pol Detiffe
BRD | Director/Board Member | 51 | - |
Director/Board Member | - | 18-06-13 | |
Bernard Courtieu
CEO | Chief Executive Officer | 60 | 07-09-05 |
François Blondel
BRD | Director/Board Member | 60 | - |
Alain Declercq
BRD | Director/Board Member | 44 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,727,332 | 2,218,298 ( 32.97 %) | 76,063 ( 1.131 %) | 32.97 % |
Company contact information
IntegraGen SA
5, rue de Henri Desbruères Génopole Campus 1, Genavenir 8
91000, Evry
+33 1 60 91 09 00
http://www.integragen.comSector
1st Jan change | Capi. | |
---|---|---|
-34.00% | 4.27M | |
-20.45% | 10.67B | |
+43.17% | 3.22B | |
-35.86% | 2.09B | |
-17.21% | 2.04B | |
-29.81% | 1.46B | |
+17.56% | 1B | |
-4.37% | 734M | |
-37.00% | 391M | |
-46.94% | 379M |
- Stock Market
- Equities
- ALINT Stock
- Company IntegraGen